mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.37 |
0.0009 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |